Sukhjit Starch Q1 FY27 Revenue Up 7.60% to ₹395.12 Cr; PAT Jumps 164%
Sukhjit Starch & Chemicals Ltd reported unaudited Q1 FY27 results with Revenue from Operations at ₹395.12 crore (up 7.60% YoY). EBITDA grew to ₹30.11 crore, and PAT surged 164.42% to ₹12.56 crore. Management cited healthy demand and cost optimization for the performance.
The results show substantial improvement in key financial metrics, which is likely to positively influence investor sentiment and the company's stock performance.
The company reported significant year-on-year growth in revenue, EBITDA, PBT, and PAT, indicating a strong financial performance.
Sukhjit Starch & Chemicals Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The company reported a revenue from operations of ₹395.12 crore, marking a 7.60% year-on-year growth from ₹367.20 crore in Q1 FY26. EBITDA for the quarter increased to ₹30.11 crore from ₹19.89 crore in the corresponding period last year, with the EBITDA margin improving by 220 basis points to 7.62%.
Profit Before Tax (PBT) saw a significant jump of 190.30%, reaching ₹16.46 crore compared to ₹5.67 crore in Q1 FY26. Similarly, Profit After Tax (PAT) surged by 164.42% to ₹12.56 crore from ₹4.75 crore in Q1 FY26.
Mr. K.K. Sardana, Managing Director, commented that Q1 FY27 was a resilient quarter characterized by healthy demand, stable raw material prices, and consistent operational execution. He highlighted focused cost optimization initiatives leading to stronger operating leverage and improved profitability. Despite certain macroeconomic factors, market demand remained resilient, supporting the company's growth trajectory. He expressed confidence in the company's ability to navigate market dynamics and deliver consistent results, capitalizing on emerging opportunities for sustainable, long-term value creation.
What to do with a filing like this
Sukhjit Starch & Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sukhjit Starch & Chemicals Limited. Read the original for the full detail.